NCT04250350 · Interventional trial
Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis
Overall registry status Completed
Phase 3
Conditions Atopic Dermatitis
Delaware Valley sites
- Paddington Testing Company Inc · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory